CYSTEAMINE HYDROCHLORIDE

CYSTEAMINE HYDROCHLORIDE was reported 662 times

CYSTEAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CYSTINOSIS 4 0.1905
1 CYSTINURIA 1 0.0556
2 CORNEAL NEOVASCULARISATION 8 0.0324
3 CONGENITAL APLASTIC ANAEMIA 1 0.0222
4 GINGIVITIS ULCERATIVE 4 0.0186
5 AMINO ACID LEVEL INCREASED 8 0.0108
6 SPONTANEOUS BACTERIAL PERITONITIS 2 0.0082
7 CORNEAL EPITHELIAL MICROCYSTS 1 0.0060
8 CONJUNCTIVITIS BACTERIAL 2 0.0058
9 PH URINE INCREASED 1 0.0058
10 NORMAL PRESSURE HYDROCEPHALUS 2 0.0049
11 TRACHEOSTOMY MALFUNCTION 1 0.0048
12 GASTRODUODENAL ULCER 2 0.0048
13 THERMAL BURNS OF EYE 1 0.0044
14 CORNEAL DEGENERATION 1 0.0041
15 ECZEMA EYELIDS 2 0.0036
16 GROSS MOTOR DELAY 1 0.0035
17 BIOPSY KIDNEY 1 0.0035
18 EAR TUBE INSERTION 1 0.0034
19 FEEDING TUBE COMPLICATION 1 0.0032
20 EYE IRRITATION 178 0.0031
21 OSTEOTOMY 1 0.0031
22 DISCONTINUED PRODUCT ADMINISTERED 1 0.0030
23 FLUID REPLACEMENT 1 0.0030
24 RETINAL INJURY 2 0.0026
25 CORNEAL TRANSPLANT 2 0.0026
26 VIRAL RASH 1 0.0025
27 THALAMUS HAEMORRHAGE 2 0.0023
28 HAEMANGIOMA OF SKIN 1 0.0023
29 PHOTOPHOBIA 42 0.0022
30 CORNEAL SCAR 1 0.0020
31 MEDICAL DEVICE CHANGE 1 0.0019
32 CATHETER SITE DISCHARGE 2 0.0018
33 RENAL TRANSPLANT 6 0.0017
34 RECTAL PROLAPSE 2 0.0017
35 EYE PAIN 83 0.0015
36 BORDERLINE PERSONALITY DISORDER 1 0.0014
37 PRODUCT DESIGN ISSUE 1 0.0014
38 ABNORMAL SENSATION IN EYE 6 0.0014
39 OCULAR HYPERAEMIA 65 0.0014
40 CONJUNCTIVITIS ALLERGIC 2 0.0013
41 CORNEAL DEPOSITS 1 0.0013
42 POST-TRAUMATIC NECK SYNDROME 1 0.0012
43 REACTION TO PRESERVATIVES 1 0.0012
44 COSTOCHONDRITIS 2 0.0012
45 EYE OEDEMA 3 0.0012
46 PERITONEAL DIALYSIS 1 0.0012
47 OESOPHAGEAL RUPTURE 1 0.0012
48 DEAFNESS BILATERAL 2 0.0012
49 VITAL FUNCTIONS ABNORMAL 1 0.0012
50 SALIVA ALTERED 1 0.0011
51 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
52 BIOPSY 1 0.0011
53 SKIN GRAFT 1 0.0011
54 EYELID MARGIN CRUSTING 3 0.0010
55 OCULAR HYPERTENSION 2 0.0010
56 EYELID RASH 1 0.0010
57 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
58 KERATITIS 3 0.0010
59 PRODUCT DIFFICULT TO SWALLOW 1 0.0010
60 EYELIDS PRURITUS 3 0.0010
61 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
62 BURNS THIRD DEGREE 1 0.0009
63 PRODUCT LOT NUMBER ISSUE 2 0.0009
64 CONJUNCTIVITIS 15 0.0008
65 EYELID IRRITATION 2 0.0008
66 PHYSICAL DECONDITIONING 2 0.0008
67 CATHETER SITE PAIN 2 0.0008
68 CORNEAL OPACITY 1 0.0007
69 CALCULUS BLADDER 1 0.0007
70 ULCERATIVE KERATITIS 2 0.0007
71 CORNEAL ABRASION 1 0.0007
72 VITREOUS HAEMORRHAGE 2 0.0007
73 FANCONI SYNDROME 1 0.0007
74 BLOOD ELECTROLYTES DECREASED 1 0.0007
75 HORDEOLUM 3 0.0007
76 NOROVIRUS INFECTION 1 0.0007
77 NEPHRECTOMY 1 0.0007
78 EYE OPERATION 3 0.0007
79 KIDNEY TRANSPLANT REJECTION 3 0.0006
80 OPTIC NERVE DISORDER 1 0.0006
81 TONSILLECTOMY 1 0.0006
82 KYPHOSIS 1 0.0006
83 NONSPECIFIC REACTION 3 0.0005
84 ACCIDENTAL DEATH 1 0.0005
85 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
86 CONCOMITANT DISEASE PROGRESSION 1 0.0005
87 SKIN ODOUR ABNORMAL 2 0.0005
88 PRODUCT USE COMPLAINT 8 0.0005
89 CELL DEATH 1 0.0005
90 HYPERPARATHYROIDISM 1 0.0005
91 SUBILEUS 1 0.0005
92 EYE PRURITUS 16 0.0005
93 FOREIGN BODY SENSATION IN EYES 3 0.0005
94 PRODUCT DISPENSING ISSUE 2 0.0005
95 PAPILLOEDEMA 2 0.0004
96 BRAIN OPERATION 1 0.0004
97 METASTATIC MALIGNANT MELANOMA 1 0.0004
98 APPENDICITIS 4 0.0004
99 EYE INFLAMMATION 4 0.0004
100 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
101 GASTROINTESTINAL TUBE INSERTION 1 0.0004
102 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
103 ANGLE CLOSURE GLAUCOMA 1 0.0004
104 EYE DISCHARGE 4 0.0004
105 ENDOTRACHEAL INTUBATION 1 0.0004
106 RENAL TUBULAR DISORDER 1 0.0004
107 PRODUCT CONTAINER ISSUE 3 0.0003
108 HERPES VIRUS INFECTION 2 0.0003
109 ADENOVIRUS INFECTION 1 0.0003
110 CRANIOCEREBRAL INJURY 1 0.0003
111 EYE INJURY 1 0.0003
112 PRODUCT ADMINISTRATION ERROR 6 0.0003
113 B-CELL LYMPHOMA 1 0.0003
114 BRONCHIOLITIS 1 0.0003
115 NEPHROPATHY TOXIC 3 0.0003
116 HYPOCALCAEMIA 5 0.0003
117 HAEMODYNAMIC INSTABILITY 2 0.0003
118 ACIDOSIS 2 0.0003
119 APHTHOUS ULCER 2 0.0003
120 PROSTATOMEGALY 1 0.0003
121 INTESTINAL STENOSIS 1 0.0002
122 DISEASE COMPLICATION 1 0.0002
123 LUMBAR VERTEBRAL FRACTURE 1 0.0002
124 RETINAL DETACHMENT 2 0.0002
125 DEVICE OCCLUSION 3 0.0002
126 HYPOVOLAEMIC SHOCK 1 0.0002
127 INCORRECT DOSAGE ADMINISTERED 1 0.0002
128 HYPERVOLAEMIA 1 0.0002
129 LACRIMATION INCREASED 6 0.0002
130 PERITONITIS 4 0.0002
131 VISION BLURRED 26 0.0002
132 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
133 PRODUCT RESIDUE PRESENT 1 0.0002
134 ERYTHEMA OF EYELID 1 0.0002
135 TREATMENT NONCOMPLIANCE 10 0.0002
136 ASTHENOPIA 1 0.0002
137 PROSTATIC DISORDER 1 0.0002
138 INTRACRANIAL PRESSURE INCREASED 1 0.0002
139 OCULAR DISCOMFORT 2 0.0002
140 EYE INFECTION 2 0.0002
141 PERIORBITAL SWELLING 1 0.0002
142 ELECTROLYTE IMBALANCE 2 0.0002
143 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
144 GENERALISED OEDEMA 2 0.0002
145 INTENTIONAL PRODUCT MISUSE 14 0.0002
146 SWELLING OF EYELID 1 0.0002
147 BURNING SENSATION 11 0.0002
148 GLAUCOMA 3 0.0002
149 KIDNEY INFECTION 3 0.0002
150 APPETITE DISORDER 1 0.0002
151 BODY TEMPERATURE INCREASED 3 0.0001
152 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
153 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
154 MAJOR DEPRESSION 1 0.0001
155 HYPOPHOSPHATAEMIA 1 0.0001
156 CEREBRAL DISORDER 1 0.0001
157 DEVICE RELATED INFECTION 2 0.0001
158 CONCUSSION 1 0.0001
159 GASTROINTESTINAL INFLAMMATION 1 0.0001
160 RENAL CYST 1 0.0001
161 PRODUCT DOSE OMISSION 8 0.0001
162 ASPHYXIA 1 0.0001
163 IMPAIRED HEALING 4 0.0001
164 DRY EYE 6 0.0001
165 SENSATION OF FOREIGN BODY 1 0.0001
166 SKIN HYPERPIGMENTATION 1 0.0001
167 BLOOD MAGNESIUM DECREASED 1 0.0001
168 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
169 PNEUMONIA BACTERIAL 1 0.0001
170 EYE SWELLING 4 0.0001
171 SQUAMOUS CELL CARCINOMA 1 0.0001
172 SALIVARY HYPERSECRETION 1 0.0001
173 BLOOD POTASSIUM DECREASED 3 0.0001
174 HELICOBACTER INFECTION 1 0.0001
175 FULL BLOOD COUNT ABNORMAL 1 0.0001
176 RETCHING 2 0.0001
177 PHARYNGITIS STREPTOCOCCAL 1 0.0001
178 SKIN LACERATION 1 0.0001
179 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
180 OESOPHAGITIS 1 0.0001
181 EYELID OEDEMA 1 0.0001
182 CHOLECYSTITIS 1 0.0001
183 BLOOD PRESSURE FLUCTUATION 2 0.0001
184 RENAL IMPAIRMENT 7 0.0001
185 LOCALISED INFECTION 2 0.0001
186 PNEUMONIA ASPIRATION 2 0.0001
187 LEUKOPENIA 4 0.0001
188 HYPOPHAGIA 2 0.0001
189 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
190 EAR INFECTION 2 0.0001
191 DEHYDRATION 10 0.0001
192 PRODUCT DOSE OMISSION ISSUE 22 0.0001
193 PRODUCT TASTE ABNORMAL 1 0.0001
194 RESPIRATORY DISTRESS 2 0.0001
195 HYPOMAGNESAEMIA 1 0.0001
196 CARDIO-RESPIRATORY ARREST 3 0.0001
197 BLINDNESS UNILATERAL 1 0.0001
198 DIALYSIS 1 0.0001
199 BRONCHOSPASM 1 0.0001
200 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
201 IMMUNODEFICIENCY 1 0.0001
202 INSURANCE ISSUE 1 0.0001
203 PNEUMOTHORAX 1 0.0001
204 ABSCESS 1 0.0001
205 CARDIAC FAILURE 5 0.0001
206 PHOTOSENSITIVITY REACTION 1 0.0001
207 RENAL FAILURE 8 0.0001
208 VIRAL INFECTION 2 0.0001
209 VOMITING 28 0.0001
210 TYPE 2 DIABETES MELLITUS 2 0.0001
211 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
212 ILLNESS 6 0.0001
213 VISUAL IMPAIRMENT 7 0.0001
214 GALLBLADDER DISORDER 1 0.0001
215 GASTROENTERITIS VIRAL 1 0.0001
216 END STAGE RENAL DISEASE 1 0.0001
217 INTESTINAL OBSTRUCTION 2 0.0001
218 BLOOD URINE PRESENT 1 0.0001
219 CHOLESTASIS 1 0.0001
220 PRESCRIBED OVERDOSE 1 0.0001
221 CHOKING 1 0.0001
222 FEEDING DISORDER 1 0.0000
223 DISCOMFORT 3 0.0000
224 BLINDNESS 2 0.0000
225 ROAD TRAFFIC ACCIDENT 2 0.0000
226 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
227 DEVICE DISLOCATION 2 0.0000
228 MENTAL DISORDER 2 0.0000
229 HOSPITALISATION 7 0.0000
230 APPLICATION SITE PAIN 1 0.0000
231 PULMONARY OEDEMA 2 0.0000
232 RASH PAPULAR 1 0.0000
233 SNEEZING 1 0.0000
234 NEPHROLITHIASIS 2 0.0000
235 DISEASE PROGRESSION 5 0.0000
236 INFECTION 6 0.0000
237 CHRONIC KIDNEY DISEASE 3 0.0000
238 HAEMATEMESIS 1 0.0000
239 THERAPY CESSATION 2 0.0000
240 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
241 UNRESPONSIVE TO STIMULI 1 0.0000
242 DIPLOPIA 1 0.0000
243 PNEUMONIA 12 0.0000
244 FREQUENT BOWEL MOVEMENTS 1 0.0000
245 FEELING COLD 1 0.0000
246 WOUND 1 0.0000
247 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
248 INTENTIONAL DOSE OMISSION 1 0.0000
249 RED BLOOD CELL COUNT DECREASED 1 0.0000
250 SEIZURE 4 0.0000
251 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
252 ABDOMINAL PAIN UPPER 7 0.0000
253 LABORATORY TEST ABNORMAL 1 0.0000
254 CATARACT 2 0.0000
255 ILL-DEFINED DISORDER 2 0.0000
256 ADVERSE EVENT 3 0.0000
257 DRUG INTOLERANCE 3 0.0000
258 NIGHT SWEATS 1 0.0000
259 SWELLING FACE 2 0.0000
260 BLOOD CREATININE INCREASED 2 0.0000
261 EYE DISORDER 1 0.0000
262 HEADACHE 19 0.0000
263 EXPIRED PRODUCT ADMINISTERED 1 0.0000
264 URINARY RETENTION 1 0.0000
265 GAIT INABILITY 1 0.0000
266 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
267 URINARY TRACT INFECTION 5 0.0000
268 THERAPY INTERRUPTED 2 0.0000
269 CEREBRAL HAEMORRHAGE 1 0.0000
270 NAUSEA 22 0.0000
271 DYSURIA 1 0.0000
272 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
273 DISORIENTATION 1 0.0000
274 ABORTION SPONTANEOUS 1 0.0000
275 THROMBOSIS 2 0.0000
276 CARDIAC ARREST 2 0.0000
277 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
278 CEREBROVASCULAR ACCIDENT 4 0.0000
279 DEVICE LEAKAGE 1 0.0000
280 SEPTIC SHOCK 1 0.0000
281 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
282 COVID-19 4 0.0000
283 TACHYCARDIA 2 0.0000
284 SKIN IRRITATION 1 0.0000
285 NASOPHARYNGITIS 4 0.0000
286 HYPOKALAEMIA 1 0.0000
287 HYPERSENSITIVITY 4 0.0000
288 RENAL DISORDER 1 0.0000
289 DYSPHAGIA 2 0.0000
290 COMA 1 0.0000
291 MIGRAINE 2 0.0000
292 DEATH 18 0.0000
293 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
294 DYSPEPSIA 2 0.0000
295 CONDITION AGGRAVATED 6 0.0000
296 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
297 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
298 RASH PRURITIC 1 0.0000
299 INFLUENZA 2 0.0000
300 SEPSIS 2 0.0000
301 ABDOMINAL DISCOMFORT 3 0.0000
302 HYPONATRAEMIA 1 0.0000
303 INCORRECT DOSE ADMINISTERED 4 0.0000
304 HERPES ZOSTER 1 0.0000
305 DECREASED APPETITE 4 0.0000
306 DIARRHOEA 11 0.0000
307 IRRITABILITY 1 0.0000
308 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
309 PRODUCT USE ISSUE 3 0.0000
310 MALAISE 7 0.0000
311 DEVICE DIFFICULT TO USE 1 0.0000
312 BLOOD PRESSURE DECREASED 1 0.0000
313 OFF LABEL USE 13 0.0000
314 ERYTHEMA 3 0.0000
315 INJURY 1 0.0000
316 HYPERTENSION 3 0.0000
317 CONSTIPATION 3 0.0000
318 UNDERDOSE 1 0.0000
319 UNEVALUABLE EVENT 1 0.0000
320 DIABETES MELLITUS 1 0.0000
321 ACUTE KIDNEY INJURY 2 0.0000
322 ABDOMINAL PAIN 3 0.0000
323 PARAESTHESIA 2 0.0000
324 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
325 BALANCE DISORDER 1 0.0000
326 PRODUCT STORAGE ERROR 1 0.0000
327 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
328 GASTROINTESTINAL DISORDER 1 0.0000
329 OROPHARYNGEAL PAIN 1 0.0000
330 CARDIAC DISORDER 1 0.0000
331 SWELLING 1 0.0000
332 PULMONARY EMBOLISM 1 0.0000
333 CONTUSION 1 0.0000
334 SOMNOLENCE 2 0.0000
335 SINUSITIS 1 0.0000
336 OVERDOSE 2 0.0000
337 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
338 MUSCULAR WEAKNESS 1 0.0000
339 PYREXIA 3 0.0000
340 CHILLS 1 0.0000
341 PAIN 5 0.0000
342 LOSS OF CONSCIOUSNESS 1 0.0000
343 DRY SKIN 1 0.0000
344 MEMORY IMPAIRMENT 1 0.0000
345 DYSPNOEA 4 0.0000
346 HYPOAESTHESIA 1 0.0000
347 FATIGUE 5 0.0000
348 DRUG DOSE OMISSION 1 0.0000
349 URTICARIA 1 0.0000
350 MYALGIA 1 0.0000
351 NO ADVERSE EVENT 1 0.0000
352 ASTHENIA 2 0.0000
353 ANAEMIA 1 0.0000
354 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
355 DEPRESSION 1 0.0000
356 BACK PAIN 1 0.0000
357 DIZZINESS 2 0.0000
358 INSOMNIA 1 0.0000
359 WEIGHT DECREASED 1 0.0000
360 PAIN IN EXTREMITY 1 0.0000
361 DRUG INEFFECTIVE 4 0.0000
362 FALL 1 0.0000
363 PRURITUS 1 0.0000
364 ARTHRALGIA 1 0.0000
365 RASH 1 0.0000